ATE377023T1 - Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene - Google Patents

Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene

Info

Publication number
ATE377023T1
ATE377023T1 AT04818758T AT04818758T ATE377023T1 AT E377023 T1 ATE377023 T1 AT E377023T1 AT 04818758 T AT04818758 T AT 04818758T AT 04818758 T AT04818758 T AT 04818758T AT E377023 T1 ATE377023 T1 AT E377023T1
Authority
AT
Austria
Prior art keywords
melittin
methods
target antigens
containing peptides
immune reactions
Prior art date
Application number
AT04818758T
Other languages
English (en)
Inventor
Rinaldo Zurbriggen
Original Assignee
Pevion Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pevion Biotech Ltd filed Critical Pevion Biotech Ltd
Application granted granted Critical
Publication of ATE377023T1 publication Critical patent/ATE377023T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
AT04818758T 2003-11-05 2004-11-05 Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene ATE377023T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51750203P 2003-11-05 2003-11-05

Publications (1)

Publication Number Publication Date
ATE377023T1 true ATE377023T1 (de) 2007-11-15

Family

ID=34619323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04818758T ATE377023T1 (de) 2003-11-05 2004-11-05 Zusammensetzungen, die von melittin abgeleitet sind und peptide enthalten, und verfahren zur potenzierung von immunreaktionen gegen target- antigene

Country Status (8)

Country Link
US (1) US7538083B2 (de)
EP (1) EP1680446B1 (de)
AT (1) ATE377023T1 (de)
AU (1) AU2004291277A1 (de)
CA (1) CA2543072A1 (de)
DE (1) DE602004009818T2 (de)
NO (1) NO20062579L (de)
WO (1) WO2005049647A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7538083B2 (en) * 2003-11-05 2009-05-26 Intercell Ag Compositions and methods for the potentiation of immune responses against target antigens
WO2007092315A2 (en) * 2006-02-03 2007-08-16 The Regents Of The University Of California Immunostimulation by cpg oligonucleotide-virus complexes
WO2007099387A1 (en) 2006-03-03 2007-09-07 Mymetics Corporation Virosome-like vesicles comprising gp41-derived antigens
US20090022799A1 (en) * 2006-10-06 2009-01-22 Shikha Pramanik Barman Compositions that contain beta-glucan to be used for the prevention and treatment of disease and methods for their use
CN103961686A (zh) 2006-11-16 2014-08-06 凯制药公司 用于治疗甲状旁腺功能亢进和高钙血症的聚阳离子钙调节肽
EP3808363B1 (de) 2009-07-29 2022-09-07 Kai Pharmaceuticals, Inc. Therapiemittel zur reduzierung der nebenschilddrüsenhormonspiegel
EP2717896B1 (de) 2011-06-08 2016-08-24 Kai Pharmaceuticals, Inc. Therapeutika zur regulierung des phosphatgehalts im serum
CN111801116A (zh) * 2017-12-15 2020-10-20 拜耳动物保健有限责任公司 免疫刺激性组合物
CN108129560B (zh) * 2017-12-15 2020-04-28 西安交通大学医学院第一附属医院 一种突变蜂毒肽MEL-pep及其应用
KR102250412B1 (ko) * 2018-05-04 2021-05-17 트윈피그바이오랩(주) 멜리틴-기반 세포사멸 유발 펩타이드로 m2 유사 종앙관련 대식세포의 표적화
CN114288404A (zh) * 2021-12-20 2022-04-08 浙江洪晟生物科技股份有限公司 一种禽苗用免疫增强剂、二联灭活疫苗及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
US5268454A (en) * 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US5235038A (en) * 1991-01-22 1993-08-10 Torry Pines Institute For Molecular Studies Deletion and substitution analogues of melittin peptide
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US5519114A (en) * 1993-10-29 1996-05-21 University Of Florida Research Foundation, Inc. Retroviral superantigens, superantigen peptides, and methods of use
JP3207429B2 (ja) * 1994-08-23 2001-09-10 株式会社ディ・ディ・エス研究所 蛋白質の修飾方法
AU7965198A (en) * 1997-06-11 1998-12-30 Board Of Regents, The University Of Texas System Anti-inflammatory and other therapeutic, prophylactic or diagnostic uses of synthetic melittin and new related peptides
US6372471B1 (en) * 1998-10-01 2002-04-16 The Rockefeller University Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
EP1499349B1 (de) * 2001-03-02 2009-11-18 The Rockefeller University Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
US7538083B2 (en) * 2003-11-05 2009-05-26 Intercell Ag Compositions and methods for the potentiation of immune responses against target antigens
WO2007099387A1 (en) * 2006-03-03 2007-09-07 Mymetics Corporation Virosome-like vesicles comprising gp41-derived antigens
EP1938835A1 (de) * 2006-12-29 2008-07-02 Pevion Biotech AG Nichtspezifische immunostimulierende Wirkstoffe

Also Published As

Publication number Publication date
US7538083B2 (en) 2009-05-26
CA2543072A1 (en) 2005-06-02
US20050196383A1 (en) 2005-09-08
WO2005049647A3 (en) 2005-08-11
EP1680446A2 (de) 2006-07-19
DE602004009818D1 (de) 2007-12-13
AU2004291277A1 (en) 2005-06-02
DE602004009818T2 (de) 2008-09-18
NO20062579L (no) 2006-06-02
WO2005049647A2 (en) 2005-06-02
EP1680446B1 (de) 2007-10-31

Similar Documents

Publication Publication Date Title
EP3424524A3 (de) Neuartige nukleinsäuremoleküle
NO20062579L (no) Preparater som omfatter melittin-avledede peptider og fremgangsmate for styrking av immunresponser mot malantigener
ATE426412T1 (de) Adjuvante influenza-vakzine
RS54133B1 (en) ANTI-IL-6 ANTIBODIES, PREPARATIONS, PREPARATION AND USE PROCEDURES
RS54127B1 (en) ANTIBODIES NEUTRALIZERS OF THE HUMAN FACTOR OF STIMULATION OF THE COLONIA OF THE GRANULLocyte MACROPHAGUS
CY1113243T1 (el) Μεθοδοι θεραπειας με χρηση αντισωματων cτlα-4
EA201000424A1 (ru) Антитела к il-23
PL375398A1 (en) Immunostimulatory nucleic acids
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
EP2182006A3 (de) Zusammensetzungen und Verfahren zur Behandlung von Immunerkrankungen
PE20071055A1 (es) Anticuerpos anti mn
CY1109465T1 (el) Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης
IL163902A0 (en) Antibodies against cancer antigen tmeff2 and uses thereof
WO2021207433A3 (en) Epitopes of sars-cov-2 neutralizing antibodies
WO2005007673A3 (en) Immunogenic peptides
EA200900738A1 (ru) Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1
WO2019152356A3 (en) Glucuronylation as acidic post-translational modification on therapeutic monoclonal antibodies
WO2004087073A3 (en) Treatment of demyelinating conditions
ATE490785T1 (de) Parathormon-antikörper und damit zusammenhängende verfahren
TW200611706A (en) Cytotoxic t lymphocyte
CR20200642A (es) Proteínas inmunodominantes y fragmentos en esclerosis múltiples
WO2019094533A8 (en) Angptl8-binding agents and methods of use thereof
WO2018170236A9 (en) CDPK1 INHIBITORS, COMPOSITIONS AND RELATED METHODS
DE69839943D1 (de) Verhinderung von immunreaktivität durch verarmung oder inhibition von antigen-präsentierenden zellen
WO2007020520A3 (en) Antigenic peptides and their use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties